U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H31FN4O8
Molecular Weight 558.5554
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ERAVACYCLINE

SMILES

[H][C@@]12CC3=C(F)C=C(NC(=O)CN4CCCC4)C(O)=C3C(=O)C1=C(O)[C@]5(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]5([H])C2

InChI

InChIKey=HLFSMUUOKPBTSM-ISIOAQNYSA-N
InChI=1S/C27H31FN4O8/c1-31(2)20-13-8-11-7-12-14(28)9-15(30-16(33)10-32-5-3-4-6-32)21(34)18(12)22(35)17(11)24(37)27(13,40)25(38)19(23(20)36)26(29)39/h9,11,13,20,34,36-37,40H,3-8,10H2,1-2H3,(H2,29,39)(H,30,33)/t11-,13-,20-,27-/m0/s1

HIDE SMILES / InChI

Molecular Formula C27H31FN4O8
Molecular Weight 558.5554
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 03:00:06 UTC 2023
Edited
by admin
on Sat Dec 16 03:00:06 UTC 2023
Record UNII
07896928ZC
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ERAVACYCLINE
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
1-PYRROLIDINEACETAMIDE, N-((5AR,6AS,7S,10AS)-9-(AMINOCARBONYL)-7-(DIMETHYLAMINO)-4-FLUORO-5,5A,6,6A,7,10,10A,12-OCTAHYDRO-1,8,10A,11-TETRAHYDROXY-10,12-DIOXO-2-NAPHTHACENYL)-
Systematic Name English
ERAVACYCLINE [USAN]
Common Name English
Eravacycline [WHO-DD]
Common Name English
TP-434
Code English
eravacycline [INN]
Common Name English
ERAVACYCLINE [MI]
Common Name English
4S,4AS,5AR,12AS)-4-(DIMETHYLAMINO)-7-FLUORO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-9-((PYRROLIDIN-1-YLACETYL)AMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE
Systematic Name English
(4S,4AS,5AR,12AS)-4-(DIMETHYLAMINO)-7-FLUORO-3,10,12,12ATETRAHYDROXY-1,11-DIOXO-9-(2-(PYRROLIDIN-1-YL)ACETAMIDO)-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE
Systematic Name English
Classification Tree Code System Code
WHO-ATC J01AA13
Created by admin on Sat Dec 16 03:00:07 UTC 2023 , Edited by admin on Sat Dec 16 03:00:07 UTC 2023
Code System Code Type Description
DRUG BANK
DB12329
Created by admin on Sat Dec 16 03:00:07 UTC 2023 , Edited by admin on Sat Dec 16 03:00:07 UTC 2023
PRIMARY
ChEMBL
CHEMBL1951095
Created by admin on Sat Dec 16 03:00:07 UTC 2023 , Edited by admin on Sat Dec 16 03:00:07 UTC 2023
PRIMARY
LACTMED
Eravacycline
Created by admin on Sat Dec 16 03:00:07 UTC 2023 , Edited by admin on Sat Dec 16 03:00:07 UTC 2023
PRIMARY
EPA CompTox
DTXSID401026285
Created by admin on Sat Dec 16 03:00:07 UTC 2023 , Edited by admin on Sat Dec 16 03:00:07 UTC 2023
PRIMARY
RXCUI
2055906
Created by admin on Sat Dec 16 03:00:07 UTC 2023 , Edited by admin on Sat Dec 16 03:00:07 UTC 2023
PRIMARY
CAS
1207283-85-9
Created by admin on Sat Dec 16 03:00:07 UTC 2023 , Edited by admin on Sat Dec 16 03:00:07 UTC 2023
PRIMARY
MERCK INDEX
m12118
Created by admin on Sat Dec 16 03:00:07 UTC 2023 , Edited by admin on Sat Dec 16 03:00:07 UTC 2023
PRIMARY
NCI_THESAURUS
C171907
Created by admin on Sat Dec 16 03:00:07 UTC 2023 , Edited by admin on Sat Dec 16 03:00:07 UTC 2023
PRIMARY
WIKIPEDIA
Eravacycline
Created by admin on Sat Dec 16 03:00:07 UTC 2023 , Edited by admin on Sat Dec 16 03:00:07 UTC 2023
PRIMARY
USAN
ZZ-69
Created by admin on Sat Dec 16 03:00:07 UTC 2023 , Edited by admin on Sat Dec 16 03:00:07 UTC 2023
PRIMARY
INN
9702
Created by admin on Sat Dec 16 03:00:07 UTC 2023 , Edited by admin on Sat Dec 16 03:00:07 UTC 2023
PRIMARY
FDA UNII
07896928ZC
Created by admin on Sat Dec 16 03:00:07 UTC 2023 , Edited by admin on Sat Dec 16 03:00:07 UTC 2023
PRIMARY
SMS_ID
100000174218
Created by admin on Sat Dec 16 03:00:07 UTC 2023 , Edited by admin on Sat Dec 16 03:00:07 UTC 2023
PRIMARY
DAILYMED
07896928ZC
Created by admin on Sat Dec 16 03:00:07 UTC 2023 , Edited by admin on Sat Dec 16 03:00:07 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET ORGANISM->INHIBITOR
MIC90
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
TARGET ORGANISM->INHIBITOR
EXCRETED UNCHANGED
FECAL
TARGET ORGANISM->INHIBITOR
MIC90
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
BINDER->LIGAND
Protein binding of eravacycline to human plasma proteins increases with increasing plasma concentrations, with 79% to 90% (bound) at plasma concentrations ranging from 100 to 10,000 ng/mL.
BINDING
EXCRETED UNCHANGED
URINE
Related Record Type Details
METABOLITE INACTIVE -> PARENT
MAJOR
METABOLITE INACTIVE -> PARENT
MAJOR
METABOLITE INACTIVE -> PARENT
MAJOR
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life ENZYMATIC
Tmax PHARMACOKINETIC
Volume of Distribution PHARMACOKINETIC